Literature DB >> 28937953

The Biological Basis of Chronic Traumatic Encephalopathy following Blast Injury: A Literature Review.

Matt Aldag1, Regina C Armstrong2, Faris Bandak3, Patrick S F Bellgowan4, Timothy Bentley5, Sean Biggerstaff6, Katrina Caravelli1, Joan Cmarik7, Alicia Crowder8, Thomas J DeGraba9, Travis A Dittmer1, Richard G Ellenbogen10, Colin Greene11, Raj K Gupta12, Ramona Hicks13, Stuart Hoffman14, Robert C Latta15, Michael J Leggieri12, Donald Marion16, Robert Mazzoli17, Michael McCrea18, John O'Donnell19, Mark Packer20, James B Petro21, Todd E Rasmussen8, Wendy Sammons-Jackson22, Richard Shoge23, Victoria Tepe20, Ladd A Tremaine24, James Zheng25.   

Abstract

The United States Department of Defense Blast Injury Research Program Coordinating Office organized the 2015 International State-of-the-Science meeting to explore links between blast-related head injury and the development of chronic traumatic encephalopathy (CTE). Before the meeting, the planning committee examined articles published between 2005 and October 2015 and prepared this literature review, which summarized broadly CTE research and addressed questions about the pathophysiological basis of CTE and its relationship to blast- and nonblast-related head injury. It served to inform participants objectively and help focus meeting discussion on identifying knowledge gaps and priority research areas. CTE is described generally as a progressive neurodegenerative disorder affecting persons exposed to head injury. Affected individuals have been participants primarily in contact sports and military personnel, some of whom were exposed to blast. The symptomatology of CTE overlaps with Alzheimer's disease and includes neurological and cognitive deficits, psychiatric and behavioral problems, and dementia. There are no validated diagnostic criteria, and neuropathological evidence of CTE has come exclusively from autopsy examination of subjects with histories of exposure to head injury. The perivascular accumulation of hyperphosphorylated tau (p-tau) at the depths of cortical sulci is thought to be unique to CTE and has been proposed as a diagnostic requirement, although the contribution of p-tau and other reported pathologies to the development of clinical symptoms of CTE are unknown. The literature on CTE is limited and is focused predominantly on head injuries unrelated to blast exposure (e.g., football players and boxers). In addition, comparative analyses of clinical case reports has been challenging because of small case numbers, selection biases, methodological differences, and lack of matched controls, particularly for blast-exposed individuals. Consequently, the existing literature is not sufficient to determine whether the development of CTE is associated with head injury frequency (e.g., single vs. multiple exposures) or head injury type (e.g., impact, nonimpact, blast-related). Moreover, the incidence and prevalence of CTE in at-risk populations is unknown. Future research priorities should include identifying additional risk factors, pursuing population-based longitudinal studies, and developing the ability to detect and diagnose CTE in living persons using validated criteria.

Entities:  

Keywords:  blast injury; chronic traumatic encephalopathy; neurodegeneration; repetitive head trauma; traumatic brain injury

Mesh:

Year:  2017        PMID: 28937953      PMCID: PMC5695742          DOI: 10.1089/neu.2017.5218

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  182 in total

1.  TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Brandon E Gavett; Robert A Stern; Christopher J Nowinski; Robert C Cantu; Neil W Kowall; Daniel P Perl; E Tessa Hedley-Whyte; Bruce Price; Chris Sullivan; Peter Morin; Hyo-Soon Lee; Caroline A Kubilus; Daniel H Daneshvar; Megan Wulff; Andrew E Budson
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

2.  Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model.

Authors:  Lee E Goldstein; Andrew M Fisher; Chad A Tagge; Xiao-Lei Zhang; Libor Velisek; John A Sullivan; Chirag Upreti; Jonathan M Kracht; Maria Ericsson; Mark W Wojnarowicz; Cezar J Goletiani; Giorgi M Maglakelidze; Noel Casey; Juliet A Moncaster; Olga Minaeva; Robert D Moir; Christopher J Nowinski; Robert A Stern; Robert C Cantu; James Geiling; Jan K Blusztajn; Benjamin L Wolozin; Tsuneya Ikezu; Thor D Stein; Andrew E Budson; Neil W Kowall; David Chargin; Andre Sharon; Sudad Saman; Garth F Hall; William C Moss; Robin O Cleveland; Rudolph E Tanzi; Patric K Stanton; Ann C McKee
Journal:  Sci Transl Med       Date:  2012-05-16       Impact factor: 17.956

3.  Current understanding of chronic traumatic encephalopathy.

Authors:  Robert A Stern; Ann C McKee; Christine M Baugh; Clifford A Robbins
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

4.  Repeated mild traumatic brain injury results in long-term white-matter disruption.

Authors:  Virginia Donovan; Claudia Kim; Ariana K Anugerah; Jacqueline S Coats; Udochuwku Oyoyo; Andrea C Pardo; Andre Obenaus
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-29       Impact factor: 6.200

5.  Longitudinal volumetric changes following traumatic brain injury: a tensor-based morphometry study.

Authors:  Kimberly D M Farbota; Aparna Sodhi; Barbara B Bendlin; Donald G McLaren; Guofan Xu; Howard A Rowley; Sterling C Johnson
Journal:  J Int Neuropsychol Soc       Date:  2012-08-13       Impact factor: 2.892

Review 6.  The clinical spectrum of sport-related traumatic brain injury.

Authors:  Barry D Jordan
Journal:  Nat Rev Neurol       Date:  2013-03-12       Impact factor: 42.937

7.  Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging.

Authors:  Lojze M Smid; Vladimir Kepe; Harry V Vinters; Mara Bresjanac; Tatsushi Toyokuni; Nagichettiar Satyamurthy; Koon-Pong Wong; Sung-Cheng Huang; Daniel H S Silverman; Karen Miller; Gary W Small; Jorge R Barrio
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Changes in the neurochemistry of athletes with repetitive brain trauma: preliminary results using localized correlated spectroscopy.

Authors:  Alexander P Lin; Saadallah Ramadan; Robert A Stern; Hayden C Box; Christopher J Nowinski; Brian D Ross; Carolyn E Mountford
Journal:  Alzheimers Res Ther       Date:  2015-03-15       Impact factor: 6.982

9.  Scale and pattern of atrophy in the chronic stages of moderate-severe TBI.

Authors:  Robin E A Green; Brenda Colella; Jerome J Maller; Mark Bayley; Joanna Glazer; David J Mikulis
Journal:  Front Hum Neurosci       Date:  2014-03-31       Impact factor: 3.169

10.  Selective vulnerability of the cerebral vasculature to blast injury in a rat model of mild traumatic brain injury.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Pierce L Janssen; Frank J Yuk; Pamela C Anazodo; Paul E Pricop; Alejandro J Paulino; Bridget Wicinski; Michael C Shaughness; Eric Maudlin-Jeronimo; Aaron A Hall; Dara L Dickstein; Richard M McCarron; Mikulas Chavko; Patrick R Hof; Stephen T Ahlers; Gregory A Elder
Journal:  Acta Neuropathol Commun       Date:  2014-06-17       Impact factor: 7.801

View more
  11 in total

Review 1.  The intersection of lifetime history of traumatic brain injury and the opioid epidemic.

Authors:  John D Corrigan; Rachel Sayko Adams
Journal:  Addict Behav       Date:  2018-10-29       Impact factor: 3.913

2.  Evaluation of the specificity of the central diagnostic criterion for chronic traumatic encephalopathy.

Authors:  Jennifer Lorigan; Hugh Kearney; Bryan Grimes; Josephine Heffernan; Alan Beausang; Jane Cryan; Michael A Farrell; Francesca M Brett
Journal:  Ir J Med Sci       Date:  2018-11-30       Impact factor: 1.568

3.  14th EUNOS Congress: PORTO, PORTUGAL, 16-19 JUNE 2019.

Authors: 
Journal:  Neuroophthalmology       Date:  2019-06-07

Review 4.  Visual deficits after traumatic brain injury.

Authors:  Pratheepa Kumari Rasiah; Ben Geier; Kumar Abhiram Jha; Rajashekhar Gangaraju
Journal:  Histol Histopathol       Date:  2021-02-18       Impact factor: 2.303

5.  Secondary-blast injury in rodents produces cognitive sequelae and distinct motor recovery trajectories.

Authors:  Jasmine Gamboa; Jessica Horvath; Amanda Simon; Md Safiqul Islam; Sijia Gao; Dror Perk; Amy Thoman; Diany Paola Calderon
Journal:  Brain Res       Date:  2021-01-07       Impact factor: 3.252

Review 6.  Chronic Traumatic Encephalopathy in Professional American Football Players: Where Are We Now?

Authors:  Tharmegan Tharmaratnam; Mina A Iskandar; Tyler C Tabobondung; Iqdam Tobbia; Prasaanthan Gopee-Ramanan; Taylor A Tabobondung
Journal:  Front Neurol       Date:  2018-06-19       Impact factor: 4.003

7.  Bibliometric Analysis of Chronic Traumatic Encephalopathy Research from 1999 to 2019.

Authors:  Bote Qi; Shuting Jin; Hongsheng Qian; Yu Zou
Journal:  Int J Environ Res Public Health       Date:  2020-07-28       Impact factor: 3.390

8.  Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.

Authors:  Hamad Yadikar; Isabel Torres; Gabrielle Aiello; Milin Kurup; Zhihui Yang; Fan Lin; Firas Kobeissy; Richard Yost; Kevin K Wang
Journal:  PLoS One       Date:  2020-07-21       Impact factor: 3.240

9.  Remote ischemic conditioning improves outcome independent of anesthetic effects following shockwave-induced traumatic brain injury.

Authors:  Eugene Park; Victoria McCutcheon; Tamar Telliyan; Elaine Liu; Rebecca Eisen; Anna Kinio; Jahan Tavakkoli; Andrew J Baker
Journal:  IBRO Rep       Date:  2019-12-17

Review 10.  Chronic traumatic encephalopathy neuropathology might not be inexorably progressive or unique to repetitive neurotrauma.

Authors:  Grant L Iverson; Andrew J Gardner; Sandy R Shultz; Gary S Solomon; Paul McCrory; Ross Zafonte; George Perry; Lili-Naz Hazrati; C Dirk Keene; Rudolph J Castellani
Journal:  Brain       Date:  2019-12-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.